Is this you?

“There is nothing more we can offer” is a sentence you are not ready to accept.

Or you heard the gentler version: “Let’s focus on quality of life.” You have spent nights reading about hyperthermia, IPT and immune therapy, and you cannot tell the evidence from the noise. You want a physician to sort it with you, honestly, and to say which of it belongs alongside the treatment you already have.

That is what this page does. It is one spoke of our integrative oncology program: it describes what the hospital combines, who the program is for, how a stay runs and how the evidence is graded for each component.

What it is

What integrative cancer treatment means at St. George Hospital

Integrative cancer treatment is the set of therapies the hospital adds to surgery, chemotherapy and radiotherapy. The aim is better local tumor control where heat can add to a drug or to radiation, better tolerance of standard treatment, and a patient who is in better condition during and after it. The components are chosen per patient from the findings and coordinated with the oncologist at home. None of them is offered as a replacement for a treatment your oncologist recommends.

The hospital has practiced integrative oncology since its founding in 1991. Dr. Julian Douwes leads infectiology, neurorehabilitation and complementary oncology and develops the treatment protocols. Dr. Martin Rößner, Chief Physician, is responsible for day-to-day clinical care and sees patients. Dr. Götte contributes to the tumor board; his direct patient care is for German patients only. The therapies themselves, with the grade of evidence behind each, are listed on the page for our oncology therapies.

Hands holding a warm cup of herbal tea over a linen tablecloth with a sprig of rosemary
Garden bench under a copper beech with a folded blanket
How we treat

The four pillars of the cancer program

Support the immune system

Immune therapy here means mistletoe injections, thymus peptides and, for selected patients, dendritic cell therapy, chosen from the immune profile taken on arrival. Whole-body hyperthermia raises the core temperature under monitoring in a session of four to six hours.

Protect the organs

Liver support, high-dose vitamin C and nutrient infusions and glutathione are given as supportive measures to carry the load of cancer metabolism and of the treatment that came before. They are supportive, and the hospital says so.

Change the terrain

Anti-inflammatory nutrition, hormonal assessment, microbiome work and stress management address the conditions under which a tumor grows. Nutritional medicine, physiotherapy and psycho-oncological support run alongside every plan.

Patient profiles

Who the program is for, and who it is not for

The program is written for patients with a confirmed diagnosis who want to add to standard oncology, or who have come to the end of what standard oncology can offer. The groups we see most often:

  • Patients in active chemotherapy or radiotherapy who want hyperthermia and immune support alongside it
  • Patients who have completed standard treatment and want a program for the months after it
  • Patients with metastatic or recurrent cancer looking for additional options after medical review
  • Patients who no longer tolerate full-dose chemotherapy and ask about low-dose alternatives
  • Patients who want a second opinion on their treatment strategy before deciding

The program is not suitable for every patient: acute medical instability, severe heart or kidney disease that rules out hyperthermia, and a performance status that no longer allows a two-week inpatient stay are the usual reasons the physicians advise against traveling. We tell you this in writing after the records review, before you book anything.

Line chart of relative blood glucose during one insulin-potentiated therapy session, with the low-dose chemotherapy given in the low-glucose window
Insulin-potentiated therapy: one session. Schematic, not to scale.
How a stay runs

Five steps from your records to the follow-up

StepWhat happensWho
1. Records reviewBefore you travel, the oncology team reads your history, pathology, imaging and prior treatment records. A video consultation in English follows, then the written estimate.Oncology physician, International Office
2. Assessment on arrivalImmune status, tumor markers, nutritional status, organ function and a physical examination in the first two days; circulating tumor cell analysis where it changes the plan.Attending physician, laboratory
3. The written planA local measure where a tumor is accessible, a heat component, a systemic component coordinated with your oncologist, and immune and supportive measures. You see the plan before it starts.Dr. Rößner with the ward team
4. Treatment weeksTwo to four weeks on the ward with a physician visit every day. Hyperthermia is scheduled around chemotherapy days; blood counts are checked before every IPT session; the plan is adjusted from the week-two measurements.Physicians and nurses on the ward
5. Discharge and follow-upA discharge report for your oncologist at home and a supplementation plan; follow-up questions go to the International Office. Some patients return for a further cycle after three to six months.Attending physician, International Office

The full sequence from first inquiry to aftercare, with what the International Office does on each day, is on the page for our integrative oncology program in Germany.

Evidence and limits

How strong the evidence is for each component

Evidence is graded on this page in four words: strong, moderate, emerging and limited. A component graded limited or emerging is an individual treatment attempt decided with the patient after medical consultation, and the physician says so before you consent.

Local-regional hyperthermia with chemotherapy or radiotherapy: strong for defined indications. A randomized phase 3 trial in 341 patients with high-risk soft-tissue sarcoma found better local progression-free survival when regional hyperthermia was added to chemotherapy (Issels et al., Lancet Oncol, 2010), and the long-term analysis found longer survival as well (Issels et al., JAMA Oncol, 2018). In recurrent breast cancer, a meta-analysis of 34 studies found complete responses more often with hyperthermia added to radiotherapy than with radiotherapy alone (Datta et al., Int J Radiat Oncol Biol Phys, 2016).

Mistletoe therapy: moderate for quality of life. A meta-analysis of nine randomized trials in breast cancer found a medium-sized improvement in quality of life (Loef et al., Integr Cancer Ther, 2023), and one randomized trial in pancreatic cancer no longer treatable by surgery, without further tumor treatment, found longer survival with mistletoe than with supportive care alone (Tröger et al., Eur J Cancer, 2013).

Supportive and mind-body measures: the Society for Integrative Oncology guideline recommends meditation, yoga, relaxation and music therapy for anxiety and mood during breast cancer treatment and acupressure or acupuncture for chemotherapy-induced nausea, and finds no strong evidence that ingested supplements manage treatment side effects (Greenlee et al., CA Cancer J Clin, 2017). High-dose vitamin C: limited for an anti-tumor effect; a randomized phase 3 trial in 442 patients with metastatic colorectal cancer found no longer progression-free survival when it was added to chemotherapy (Wang et al., Clin Cancer Res, 2022). Whole-body hyperthermia in oncology, IPT and dendritic cell therapy: emerging to limited, from cohort and early-phase data.

What the evidence does not show is a survival benefit for the integrative program as a whole in a controlled trial, and the hospital does not claim one. What we can show is the measurement: tumor markers, immune status and organ function before the first session and again in week two, documented in the report your oncologist receives.

Costs and billing

Treatment at St. George Hospital is self-pay. Costs are individual: a package price plus individual add-ons, set out in a written, itemized cost overview after a physician has read your findings. A deposit is paid before admission. After the stay you receive an itemized invoice in English that you can submit to your insurer; reimbursement is not promised. How this works in detail is on costs and insurance.

Traveling here

Patients from more than 60 countries have been treated on the ward. Munich Airport is about 60 minutes by car; the International Office arranges the transfer (charged extra) and accommodation for a companion. The practical side is under information for international patients. For background reading, the journal has a guide to integrative oncology.

FAQ

Questions patients ask about integrative cancer treatment

Does integrative cancer treatment replace chemotherapy, surgery or radiotherapy?

No. Everything on this page is added to the treatment your oncologist recommends, or follows it. The hospital does not stop or change cancer medication on its own; where a regimen can be given on the ward, it is given in coordination with the oncologist at home, and hyperthermia is scheduled around the infusion days.

Which component has the strongest evidence?

Local-regional hyperthermia added to chemotherapy or radiotherapy. A randomized phase 3 trial in high-risk soft-tissue sarcoma found better local control and, in the long-term analysis, longer survival with regional hyperthermia added to chemotherapy, and a meta-analysis in recurrent breast cancer found more complete responses with hyperthermia added to radiotherapy than with radiotherapy alone.

Which cancers do you treat?

Most solid tumors and some cancers of the blood. Breast, prostate, colorectal, lung and pancreatic cancer and lymphoma are the most frequent diagnoses on the ward. The oncology team reads your pathology, imaging and treatment summary before the video consultation and tells you in writing whether the program is reasonable for your type and stage.

Can I come while I am still in chemotherapy?

Yes, in most cases. Bring your treatment plan and the dates of your last cycle. The physician fits hyperthermia and the immune and infusion components around the chemotherapy days, and certain regimens can be continued on the ward after coordination with your oncologist. Blood counts are checked before every session that could affect them.

What does an individual treatment attempt mean?

It is a therapy that is not part of guideline oncology and whose evidence is limited or emerging, offered after the physician has explained what is known and what is not, and only with your written consent. At our hospital that applies to IPT and photodynamic therapy outside its approved indications.

How much does the program cost?

This page lists no prices. After a physician has reviewed your findings, you receive a written, itemized cost overview: a package price plus individual add-ons. Nothing is booked before you have it. Details are on costs and insurance.

If you want to know which of these components belong in your plan, send your pathology, imaging and treatment summary. The oncology team reads them before the video consultation and answers in writing.

References

  1. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.. Lancet Oncol 2010. PMID 20434400
  2. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.. JAMA Oncol 2018. PMID 29450452
  3. Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis.. Int J Radiat Oncol Biol Phys 2016. PMID 26899950
  4. Quality of Life in Breast Cancer Patients Treated With Mistletoe Extracts: A Systematic Review and Meta-Analysis.. Integr Cancer Ther 2023. PMID 37888846
  5. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.. Eur J Cancer 2013. PMID 23890767
  6. A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).. Clin Cancer Res 2022. PMID 35929990
  7. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.. CA Cancer J Clin 2017. PMID 28436999

Send a free inquiry

The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.

Hours
Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.

Munich Airport (MUC), about 60 minutes by car.

CallSend a free inquiry